A comprehensive view of neurological / cognitive health. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Consumer Wellness Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Patent Issued for Electrodermal activity acquisition (USPTO 11944420)
Published: April 19, 2024 by Information Technology Business Daily
Patent Issued for Neuromodulation energy application techniques (USPTO 11944490)
Published: April 18, 2024 by Energy Business Daily
GlobalData: Eli Lilly set to reshape pharmaceutical landscape with obesity and Alzheimer's treatments, Mounjaro and donanemab; both drugs poised to beat market expectations, with Mounjaro's sales poised to reach US$34B in 2029, more than double Wegovy's
Published: April 17, 2024 by GlobalData Plc
Phase 3 study of Roche's OCREVUS subcutaneous injection shows near-complete suppression of multiple sclerosis relapse activity and lesions; approval anticipated from FDA and EMA in 2024
Published: April 17, 2024 by F. Hoffmann-La Roche Ltd. (Roche)
Sage Therapeutics announces topline results from Phase 2 PRECEDENT Study of Dalzanemdor SAGE-718 in the treatment of mild cognitive impairment in Parkinson’s disease
Published: April 17, 2024 by Sage Therapeutics

Ask us about our Consumer Wellness market view

Trending Chart

Interactive chart with headline count